Exelixis Inc.

Exelixis Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
298.04 M
Public Float
255.61 M
Exelixis Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.08
Market Cap
$6.37 B
Shares Outstanding
301.77 M
Public Float
289.93 M

Profile

Address
1851 Harbor Bay
Parkway Alameda California 94502
United States
Employees -
Website http://www.exelixis.com
Updated 07/08/2019
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S.

Financials

View All

Charles M. Cohen
Independent Director
Michael M. Morrissey
President, Chief Executive Officer & Director